arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

Abpro Holdings, Inc.

ABPO
Price unavailable
Healthcare ·Biological Products, (No Diagnostic Substances) ·USBiological Products, (No Diagnostic Substances)
21 Visible periods
20 Metrics
Peer-ranked Benchmarks
Price Chart
61
Health
Fair
Bullish
auto_awesome

Analytical Summary

Abpro Holdings, Inc. shows strong fundamentals with top-quartile Return on Common Equity (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap
Dividend Yield
Revenue Growth
Op. Margin
ROIC 26.3%
FCF / Share $-0.46
Trailing P/E
Price / Book
FCF Yield
Debt / Equity
info Valuation on last close.

21-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Net Income Profit after all expenses
$-1.03M
↑ +73.6%
FCF / Share Free cash flow per share
$-0.46
↓ -1272.1%
trending_up

Bullish Indicators

  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Returns
94
Financial Health
7
Cash Quality
87

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 6 years · 21 quarters